![conference banner](/images/conference-banner.jpeg)
Abstract
From uncertain beginnings over four decades ago, heart transplantation is now the definitive therapy for end-stage heart failure. This review will attempt to comprehensively cover the broad gamut of anesthetic, hemodynamic, antimicrobial, immunosuppressive and hemostatic agents used by the cardiothoracic anesthesiologist in the perioperative management of patients with endstage heart disease.
Keywords: Heart failure, heart transplantation, volatile anesthetics, opioids, benzodiazepines, immunosuppresants
Current Clinical Pharmacology
Title:Anesthetic Pharmacology and Perioperative Considerations for Heart Transplantation
Volume: 10 Issue: 1
Author(s): Harish Ramakrishna, Kent H. Rehfeldt and Octavio E. Pajaro
Affiliation:
Keywords: Heart failure, heart transplantation, volatile anesthetics, opioids, benzodiazepines, immunosuppresants
Abstract: From uncertain beginnings over four decades ago, heart transplantation is now the definitive therapy for end-stage heart failure. This review will attempt to comprehensively cover the broad gamut of anesthetic, hemodynamic, antimicrobial, immunosuppressive and hemostatic agents used by the cardiothoracic anesthesiologist in the perioperative management of patients with endstage heart disease.
Export Options
About this article
Cite this article as:
Ramakrishna Harish, Rehfeldt H. Kent and Pajaro E. Octavio, Anesthetic Pharmacology and Perioperative Considerations for Heart Transplantation, Current Clinical Pharmacology 2015; 10 (1) . https://dx.doi.org/10.2174/1574884709666140212104958
DOI https://dx.doi.org/10.2174/1574884709666140212104958 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Procedural (Conscious) Sedation and Analgesia in Emergency Setting: How to
Choose Agents?
Current Pharmaceutical Design Recent Advancement and Technological Aspects of Pulsatile Drug Delivery System - A Laconic Review
Current Drug Targets Access to Opioids for Patients with Advanced Disease
Current Pharmaceutical Design Fibrinolytic Enzyme - An Overview
Current Pharmaceutical Biotechnology Cardiovascular Effects of Omega-3 Free Fatty Acids.
Current Vascular Pharmacology The Role of Anti-Inflammatory Drugs in Respiratory Diseases - Pirfenidone, Penicillamine, Chloroquine and Chlorambucil
Current Respiratory Medicine Reviews Role of Secondary Alcohol Metabolites in Anthracycline Cardiotoxicity: from Hypotheses to New Drugs
Drug Design Reviews - Online (Discontinued) Antiphospholipid Syndrome: Characteristics and Obstetrical Management
Current Drug Targets In-Vitro and In-Vivo Pharmacological Activities with Phytochemical Evaluation of Methanolic Extract of Microcos paniculata Stem Barks
Current Drug Therapy Reactive Oxygen Species, Nitric Oxide and Hypertensive Endothelial Dysfunction
Current Hypertension Reviews Cardiac Adrenomedullin: Its Role in Cardiac Hypertrophy and Heart Failure
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives
Current Drug Targets In Vitro Anticancer Effects of Two New Potent Hydrazide Compounds on Leukemic Cells
Anti-Cancer Agents in Medicinal Chemistry Advances on PPARγ Research in the Emerging Era of Precision Medicine
Current Drug Targets Nutrigenomics and its Impact on Life Style Associated Metabolic Diseases
Current Genomics Structural and Functional Characterization of a Mutant of Pseudocerastes persicus Natriuretic Peptide
Protein & Peptide Letters Eating Disorders in Athletes: From Risk Management to Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Hypertension and Endothelial Dysfunction: Therapeutic Approach
Current Vascular Pharmacology Epidural Analgesia in the Post-Anaesthesia Care Unit
Current Drug Targets Therapies Targeting Inflammation After Stent Implantation
Current Vascular Pharmacology